CIP
AGN

Chartwell Investment Partners’s Allergan plc AGN Stock Holding History

Chartwell Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,000
Closed -$2.87M – 433
2017
Q3 		$2.87M Hold
14,000
– – 0.1% 267
2017
Q2 		$3.4M Hold
14,000
– – 0.13% 220
2017
Q1 		$3.35M Hold
14,000
– – 0.12% 219
2016
Q4 		$2.94M Hold
14,000
– – 0.1% 276
2016
Q3 		$3.22M Hold
14,000
– – 0.06% 309
2016
Q2 		$3.23M Buy
14,000
+1,500
+12% +$346K 0.06% 285
2016
Q1 		$3.35M Buy
12,500
+2,500
+25% +$716K 0.06% 241
2015
Q4 		$3.13M Hold
10,000
– – 0.06% 250
2015
Q3 		$2.72M Sell
10,000
-205,380
-95% -$63.1M 0.06% 255
2015
Q2 		$65.4M Buy
215,380
+49,600
+30% +$14.8M 1.28% 7
2015
Q1 		$49.3M Buy
165,780
+35,345
+27% +$10.1M 0.96% 18
2014
Q4 		$33.6M Sell
130,435
-99,200
-43% -$24.8M 0.7% 19
2014
Q3 		$55.4M Sell
229,635
-1,825
-0.8% -$408K 1.25% 3
2014
Q2 		$51.6M Buy
+231,460
New +$47.9M 1.08% 5

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Chartwell Investment Partners's AGN Position: Q4 2017 in Review

Chartwell Investment Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 14,000 shares — an estimated $2.87M sold.

Chartwell Investment Partners first reported a position in AGN in Q2 2014 and held it in 14 quarters. The position peaked at $65.4M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Chartwell Investment Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Chartwell Investment Partners sold 14,000 Allergan plc shares in Q4 2017, an estimated $2.87M.
  • Chartwell Investment Partners first reported a position in Allergan plc in Q2 2014 and held it in 14 quarters.
  • Chartwell Investment Partners's Allergan plc position peaked at $65.4M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Chartwell Investment Partners's 13F filing for Q4 2017, filed 8 Feb 2018.